These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2786843)

  • 1. Antibody to the outer membrane proteins is the dominant opsonic antibody in normal human serum against H. influenzae type b.
    Hetherington SV
    Immunology; 1989 May; 67(1):87-91. PubMed ID: 2786843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement component 3 binding to Haemophilus influenzae type b in the presence of anticapsular and anti-outer membrane antibodies.
    Hetherington SV; Patrick CC
    Infect Immun; 1992 Jan; 60(1):19-24. PubMed ID: 1729183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b.
    Amir J; Scott MG; Nahm MH; Granoff DM
    J Infect Dis; 1990 Jul; 162(1):163-71. PubMed ID: 2355193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of human IgG, IgM, and IgA antibody directed to the capsule of Haemophilus influenzae type b.
    Schreiber JR; Barrus V; Cates KL; Siber GR
    J Infect Dis; 1986 Jan; 153(1):8-16. PubMed ID: 3484506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human antibody response to outer membrane proteins and fimbriae of Haemophilus influenzae type b.
    Erwin AL; Kenny GE; Smith AL; Stull TL
    Can J Microbiol; 1988 Jun; 34(6):723-9. PubMed ID: 2904834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opsonic capacity of a hyperimmune serum against outer membrane proteins of Klebsiella pneumoniae.
    Alcántar-Curiel MD; Muy-Rivera M; García-Latorre E; Santos Preciado JI
    Arch Med Res; 1992; 23(3):93-8. PubMed ID: 1339226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsonophagocytic effect of antibody against recombinant conserved 40-kDa outer membrane protein of Porphyromonas gingivalis.
    Saito S; Hayakawa M; Takiguchi H; Abiko Y
    J Periodontol; 1999 Jun; 70(6):610-7. PubMed ID: 10397516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target antigens for bactericidal and opsonizing antibodies to Haemophilus influenzae.
    Dahlberg-Lagergård T
    Acta Pathol Microbiol Immunol Scand C; 1982 Aug; 90(4):209-16. PubMed ID: 6982592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins.
    Gnehm HE; Pelton SI; Gulati S; Rice PA
    J Clin Invest; 1985 May; 75(5):1645-58. PubMed ID: 3873475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outer membrane protein binding sites of complement component 3 during opsonization of Haemophilus influenzae.
    Hetherington SV; Patrick CC; Hansen EJ
    Infect Immun; 1993 Dec; 61(12):5157-63. PubMed ID: 7693595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
    Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM
    J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
    Schlesinger Y; Granoff DM
    JAMA; 1992 Mar; 267(11):1489-94. PubMed ID: 1538539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiencies in opsonic defense to pneumococci in the human newborn despite adequate levels of complement and specific IgG antibodies.
    Geelen SP; Fleer A; Bezemer AC; Gerards LJ; Rijkers GT; Verhoef J
    Pediatr Res; 1990 May; 27(5):514-8. PubMed ID: 2345679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-dependent alternative pathway killing of Haemophilus influenzae type b.
    Steele NP; Munson RS; Granoff DM; Cummins JE; Levine RP
    Infect Immun; 1984 May; 44(2):452-8. PubMed ID: 6609128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the opsonic and complement triggering activity of human monoclonal IgG1 and IgM antibody against group B streptococci.
    Shyur SD; Raff HV; Bohnsack JF; Kelsey DK; Hill HR
    J Immunol; 1992 Mar; 148(6):1879-84. PubMed ID: 1541826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Haemophilus influenzae type b opsonins by neutrophil chemiluminescence.
    Kaplan SL; Umstead CL; Mason EO; Anderson DC; Parke JC; Feigin RD
    J Clin Microbiol; 1981 Mar; 13(3):532-9. PubMed ID: 6972383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opsonophagocidal activity in sera from infants and children immunized with Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate).
    Gray BM
    Pediatrics; 1990 Apr; 85(4 Pt 2):694-7. PubMed ID: 2107521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenic outer-membrane proteins of Haemophilus influenzae type b in infection.
    Langford PR; Williams AE; Moxon ER
    J Gen Microbiol; 1992 Jan; 138(1):155-9. PubMed ID: 1556547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective opsonic activity of antibodies against fibronectin-binding proteins (FnBPs) of Staphylococcus aureus.
    Rozalska B; Wadström T
    Scand J Immunol; 1993 May; 37(5):575-80. PubMed ID: 8484103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outer membrane proteins of nontypable Haemophilus influenzae and reactivity of paired sera from infected patients with their homologous isolates.
    Hansen MV; Musher DM; Baughn RE
    Infect Immun; 1985 Mar; 47(3):843-6. PubMed ID: 3871735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.